Nurix Therapeutics
NRIX
NRIX
106 hedge funds and large institutions have $568M invested in Nurix Therapeutics in 2022 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 46 increasing their positions, 30 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
9% less funds holding
Funds holding: 117 → 106 (-11)
41% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 22
Holders
106
Holding in Top 10
4
Calls
$2.14M
Puts
–
Top Buyers
| 1 | +$30.9M | |
| 2 | +$18.1M | |
| 3 | +$10.5M | |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$9.08M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$8.47M |
Top Sellers
| 1 | -$10M | |
| 2 | -$9.07M | |
| 3 | -$4.48M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
-$3.56M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$3.07M |